[225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer
Authors
- Anjong Florence Tikum (ORCID: https://orcid.org/0000-0003-4136-3601)
- Maruti Uppalapati (ORCID: https://orcid.org/0000-0003-0101-2030)
- Jessica Pougoue Ketchemen (ORCID: https://orcid.org/0000-0002-4574-8720)
- Emmanuel Nwangele (ORCID: https://orcid.org/0000-0002-4269-822X)
- Humphrey Fonge (ORCID: https://orcid.org/0000-0001-9388-6872)
- Hanan Babeker (ORCID: https://orcid.org/0000-0001-9163-1323)
- Nikita Henning
- Dede Api Fon
- Fabrice Ngoh Njotu
- Alireza Doroudi
Institutions
- University of Saskatchewan (CA)
- Hôtel-Dieu de Québec (CA)
- Université Laval (CA)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1186/s13058-026-02220-z
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00